{"entity":{"type":"insider","cik":"0001553150","url":"/insider/0001553150","json_url":"/insider/0001553150.json","name":"Walker Paul Edward","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":25,"first":"2019-05-09","last":"2026-03-12","span_basis":"filed_date"},"name_variants":[{"name":"Walker Paul Edward","source":"filing","n_filings":25,"first_seen":"2019-05-09","last_seen":"2026-03-12"}],"transactions":[{"id":6058832,"accession":"0001193125-26-104714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-104714","line_url":"/filing/0001193125-26-104714#line-1","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Korro Bio, Inc.","issuer_ticker":"KRRO","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":207100.0,"shares_display":"207,100","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":2300881.0,"total_display":"2,300,881.00","total_whole":"2,300,881","shares_owned_after":1297893.0,"shares_owned_after_display":"1,297,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-12","scope":"insider"},{"id":5797092,"accession":"0001193125-26-046662","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-046662","line_url":"/filing/0001193125-26-046662#line-7","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"SpyGlass Pharma, Inc.","issuer_ticker":"SGP","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937500.0,"shares_display":"937,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":6035038.0,"shares_owned_after_display":"6,035,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":5107994,"accession":"0001193125-25-232143","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001193125-25-232143","line_url":"/filing/0001193125-25-232143","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"NeueHealth, Inc.","issuer_ticker":"NEUE","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3915.0,"shares_display":"3,915","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":26426.25,"total_display":"26,426.25","total_whole":"26,426","shares_owned_after":1654334.0,"shares_owned_after_display":"1,654,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider","n_lines":4},{"id":2652146,"accession":"0000950170-24-139630","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139630","line_url":"/filing/0000950170-24-139630#line-1","is_derivative":false,"issuer_cik":"0001094038","issuer_name":"Marker Therapeutics, Inc.","issuer_ticker":"MRKR","issuer_name_source":null,"issuer_url":"/issuer/0001094038","owner_cik":null,"owner_name":"BASKETT FOREST; Behbahani Ali; Chang Carmen; Florence Anthony A. Jr.; Makhzoumi Mohamad; NEA 16 GP, LLC; NEA Partners 16, L.P.; New Enterprise Associates 16, L.P.; SANDELL SCOTT D; Walker Paul Edward","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":554250.0,"shares_display":"554,250","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":1773600.0,"total_display":"1,773,600.00","total_whole":"1,773,600","shares_owned_after":1625678.0,"shares_owned_after_display":"1,625,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-23","scope":"insider"},{"id":2515869,"accession":"0000950170-24-107544","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-107544","line_url":"/filing/0000950170-24-107544#line-3","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":8000000.0,"total_display":"8,000,000.00","total_whole":"8,000,000","shares_owned_after":3614486.0,"shares_owned_after_display":"3,614,486","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2236458,"accession":"0000950170-24-047683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-047683","line_url":"/filing/0000950170-24-047683#line-1","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Korro Bio, Inc.","issuer_ticker":"KRRO","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17857.0,"shares_display":"17,857","price_per_share":56.0,"price_display":"56.00","price_state":"stated","total_value":999992.0,"total_display":"999,992.00","total_whole":"999,992","shares_owned_after":1090793.0,"shares_owned_after_display":"1,090,793","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-22","filed_date":"2024-04-24","scope":"insider"},{"id":7815934,"accession":"0001209191-23-042804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042804","line_url":"/filing/0001209191-23-042804#line-1","is_derivative":false,"issuer_cik":"0001160308","issuer_name":"Savara Inc","issuer_ticker":"SVRA","issuer_name_source":null,"issuer_url":"/issuer/0001160308","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":24471264.0,"shares_owned_after_display":"24,471,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":6330954,"accession":"0001209191-22-051146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-051146","line_url":"/filing/0001209191-22-051146","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Allakos Inc.","issuer_ticker":"ALLK","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3984000.0,"shares_display":"3,984,000","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":19999680.0,"total_display":"19,999,680.00","total_whole":"19,999,680","shares_owned_after":3386400.0,"shares_owned_after_display":"3,386,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-23","scope":"insider","n_lines":2},{"id":6728324,"accession":"0001209191-22-032331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-032331","line_url":"/filing/0001209191-22-032331#line-2","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4445093.0,"shares_display":"4,445,093","price_per_share":0.0816,"price_display":"0.08","price_state":"stated","total_value":362719.5888,"total_display":"362,719.59","total_whole":"362,720","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider"},{"id":6728321,"accession":"0001209191-22-032331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-032331","line_url":"/filing/0001209191-22-032331#line-1","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5931843.0,"shares_display":"5,931,843","price_per_share":0.0654,"price_display":"0.07","price_state":"stated","total_value":387942.5322,"total_display":"387,942.53","total_whole":"387,943","shares_owned_after":4445093.0,"shares_owned_after_display":"4,445,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider"},{"id":6572774,"accession":"0001209191-22-024322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024322","line_url":"/filing/0001209191-22-024322","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3580526.0,"shares_display":"3,580,526","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":6802999.4,"total_display":"6,802,999.40","total_whole":"6,802,999","shares_owned_after":10421428.0,"shares_owned_after_display":"10,421,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider","n_lines":2},{"id":5407262,"accession":"0001209191-21-071274","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-071274","line_url":"/filing/0001209191-21-071274","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Metacrine, Inc.","issuer_ticker":"MTCR","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":459700.0,"shares_display":"459,700","price_per_share":0.9677028401131172,"price_display":"0.97","price_state":"stated","total_value":444852.9956,"total_display":"444,853.00","total_whole":"444,853","shares_owned_after":2734189.0,"shares_owned_after_display":"2,734,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-27","scope":"insider","n_lines":2},{"id":5407256,"accession":"0001209191-21-071274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-071274","line_url":"/filing/0001209191-21-071274#line-1","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Metacrine, Inc.","issuer_ticker":"MTCR","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37570.0,"shares_display":"37,570","price_per_share":1.321,"price_display":"1.32","price_state":"stated","total_value":49629.97,"total_display":"49,629.97","total_whole":"49,630","shares_owned_after":3022957.0,"shares_owned_after_display":"3,022,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-27","scope":"insider"},{"id":5171593,"accession":"0001209191-21-061098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-061098","line_url":"/filing/0001209191-21-061098#line-1","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1851852.0,"shares_display":"1,851,852","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":7789850.0,"shares_owned_after_display":"7,789,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-19","scope":"insider"},{"id":5162336,"accession":"0001209191-21-044050","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-044050","line_url":"/filing/0001209191-21-044050#line-4","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1050000.0,"shares_display":"1,050,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":19950000.0,"total_display":"19,950,000.00","total_whole":"19,950,000","shares_owned_after":7692298.0,"shares_owned_after_display":"7,692,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider"},{"id":4141008,"accession":"0001209191-21-044200","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-044200","line_url":"/filing/0001209191-21-044200","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Bright Health Group Inc.","issuer_ticker":"BHG","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1944444.0,"shares_display":"1,944,444","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":34999992.0,"total_display":"34,999,992.00","total_whole":"34,999,992","shares_owned_after":23983073.0,"shares_owned_after_display":"23,983,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider","n_lines":2},{"id":4666035,"accession":"0001209191-21-021818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-021818","line_url":"/filing/0001209191-21-021818#line-1","is_derivative":false,"issuer_cik":"0001094038","issuer_name":"Marker Therapeutics, Inc.","issuer_ticker":"MRKR","issuer_name_source":null,"issuer_url":"/issuer/0001094038","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5714285.0,"shares_display":"5,714,285","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":9999998.75,"total_display":"9,999,998.75","total_whole":"9,999,999","shares_owned_after":10714285.0,"shares_owned_after_display":"10,714,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-18","scope":"insider"},{"id":5188965,"accession":"0001209191-21-000448","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-000448","line_url":"/filing/0001209191-21-000448","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Allakos Inc.","issuer_ticker":"ALLK","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35023.0,"shares_display":"35,023","price_per_share":140.46134822830712,"price_display":"140.46","price_state":"stated","total_value":4919377.799,"total_display":"4,919,377.80","total_whole":"4,919,378","shares_owned_after":2163482.0,"shares_owned_after_display":"2,163,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-31","filed_date":"2021-01-04","scope":"insider","n_lines":3},{"id":5188947,"accession":"0001209191-21-000448","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-000448","line_url":"/filing/0001209191-21-000448","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Allakos Inc.","issuer_ticker":"ALLK","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68392.0,"shares_display":"68,392","price_per_share":141.7103278716809,"price_display":"141.71","price_state":"stated","total_value":9691852.7438,"total_display":"9,691,852.74","total_whole":"9,691,853","shares_owned_after":2231744.0,"shares_owned_after_display":"2,231,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider","n_lines":4},{"id":2446049,"accession":"0001209191-20-061976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-061976","line_url":"/filing/0001209191-20-061976#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4398602.0,"shares_display":"4,398,602","price_per_share":0.622,"price_display":"0.62","price_state":"stated","total_value":2735930.444,"total_display":"2,735,930.44","total_whole":"2,735,930","shares_owned_after":6451056.0,"shares_owned_after_display":"6,451,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-07","scope":"insider"},{"id":2689441,"accession":"0001209191-20-051535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-051535","line_url":"/filing/0001209191-20-051535#line-3","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Metacrine, Inc.","issuer_ticker":"MTCR","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":769230.0,"shares_display":"769,230","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":3060527.0,"shares_owned_after_display":"3,060,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-22","scope":"insider"},{"id":2141474,"accession":"0001209191-20-043872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-043872","line_url":"/filing/0001209191-20-043872#line-1","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3151260.0,"shares_display":"3,151,260","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":7090335.0,"total_display":"7,090,335.00","total_whole":"7,090,335","shares_owned_after":10376936.0,"shares_owned_after_display":"10,376,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-24","filed_date":"2020-07-28","scope":"insider"},{"id":2141214,"accession":"0001209191-20-039845","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-039845","line_url":"/filing/0001209191-20-039845#line-4","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Akouos, Inc.","issuer_ticker":"AKUS","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":588235.0,"shares_display":"588,235","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":9999995.0,"total_display":"9,999,995.00","total_whole":"9,999,995","shares_owned_after":4294207.0,"shares_owned_after_display":"4,294,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-30","filed_date":"2020-07-01","scope":"insider"},{"id":2644876,"accession":"0001209191-20-024290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-024290","line_url":"/filing/0001209191-20-024290#line-1","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":564.0,"shares_display":"564","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":1500.24,"total_display":"1,500.24","total_whole":"1,500","shares_owned_after":5937998.0,"shares_owned_after_display":"5,937,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-03","filed_date":"2020-04-13","scope":"insider"},{"id":7979481,"accession":"0001209191-19-043063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-043063","line_url":"/filing/0001209191-19-043063#line-2","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6750000.0,"total_display":"6,750,000.00","total_whole":"6,750,000","shares_owned_after":4186243.0,"shares_owned_after_display":"4,186,243","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-24","scope":"insider"},{"id":8514324,"accession":"0001209191-19-029405","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-029405","line_url":"/filing/0001209191-19-029405","is_derivative":false,"issuer_cik":"0001553150","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001553150","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500000.0,"shares_display":"2,500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":25000000.0,"total_display":"25,000,000.00","total_whole":"25,000,000","shares_owned_after":4438562.0,"shares_owned_after_display":"4,438,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-09","filed_date":"2019-05-13","scope":"insider","n_lines":2},{"id":9270877,"accession":"0001209191-19-028710","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-028710","line_url":"/filing/0001209191-19-028710#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1136704.0,"shares_display":"1,136,704","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":1227640.32,"total_display":"1,227,640.32","total_whole":"1,227,640","shares_owned_after":2052454.0,"shares_owned_after_display":"2,052,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-07","filed_date":"2019-05-10","scope":"insider"},{"id":8598479,"accession":"0001209191-19-028608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-028608","line_url":"/filing/0001209191-19-028608#line-1","is_derivative":false,"issuer_cik":"0001505512","issuer_name":"Regulus Therapeutics Inc.","issuer_ticker":"RGLS","issuer_name_source":null,"issuer_url":"/issuer/0001505512","owner_cik":"0001553150","owner_name":"Walker Paul Edward","owner_display_name":"Walker Paul Edward","owner_url":"/insider/0001553150","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1136704.0,"shares_display":"1,136,704","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":1227640.32,"total_display":"1,227,640.32","total_whole":"1,227,640","shares_owned_after":2052454.0,"shares_owned_after_display":"2,052,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-07","filed_date":"2019-05-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":23,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Korro Bio, Inc.","url":"/issuer/0001703647","role":"Ten percent owner","n_filings":2,"first_seen":"2024-04-24","last_seen":"2026-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001778922","name":"SpyGlass Pharma, Inc.","url":"/issuer/0001778922","role":"Ten percent owner","n_filings":1,"first_seen":"2026-02-11","last_seen":"2026-02-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001671284","name":"NeueHealth, Inc.","url":"/issuer/0001671284","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-06-30","last_seen":"2025-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001094038","name":"Marker Therapeutics, Inc.","url":"/issuer/0001094038","role":"Ten percent owner","n_filings":2,"first_seen":"2021-03-18","last_seen":"2024-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Ten percent owner","n_filings":1,"first_seen":"2024-09-17","last_seen":"2024-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001160308","name":"Savara Inc","url":"/issuer/0001160308","role":"Ten percent owner","n_filings":1,"first_seen":"2023-07-19","last_seen":"2023-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001564824","name":"Allakos Inc.","url":"/issuer/0001564824","role":"Director","n_filings":2,"first_seen":"2021-01-04","last_seen":"2022-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Ten percent owner","n_filings":2,"first_seen":"2020-07-28","last_seen":"2022-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001563880","name":"Trevi Therapeutics, Inc.","url":"/issuer/0001563880","role":"Ten percent owner","n_filings":4,"first_seen":"2019-05-13","last_seen":"2022-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001634379","name":"Metacrine, Inc.","url":"/issuer/0001634379","role":"Ten percent owner","n_filings":2,"first_seen":"2020-09-22","last_seen":"2021-12-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-30","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001505512","name":"Regulus Therapeutics Inc.","url":"/issuer/0001505512","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2019-05-09","last_seen":"2020-12-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001722271","name":"Akouos, Inc.","url":"/issuer/0001722271","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-01","last_seen":"2020-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-24","last_seen":"2019-07-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553150","retrieved_at":"2026-08-24T08:26:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}